23 results on '"Wu, Jianhong"'
Search Results
2. Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective.
- Author
-
Bragazzi, Nicola Luigi, Woldegerima, Woldegebriel Assefa, Wu, Jianhong, Converti, Manlio, Szarpak, Lukasz, Crapanzano, Andrea, Odeh, Marwan, Farah, Raymond, and Khamisy-Farah, Rola
- Subjects
MONKEYPOX ,NONBINARY people ,TRANS women ,CRITICAL analysis ,SCIENTIFIC literature - Abstract
The 2022–2023 Mpox multi-country outbreak, identified in over 110 WHO Member States, revealed a predominant impact on cisgender men, particularly those engaging in sex with men, while less frequently affecting women. This disparity prompted a focused investigation into the gender-specific characteristics of Mpox infections, particularly among women, to address a notable knowledge gap. This review systematically gathers and analyzes the scientific literature and case reports concerning Mpox infections in women, covering a broad geographical spectrum including regions such as Argentina, Brazil, Colombia, Nigeria, Europe, Vietnam, and the United States. The analysis delves into various aspects of Mpox in women, including clinical features, epidemiology, psychological impacts, preparedness strategies, and case studies, with particular attention to pregnant women and those with underlying health conditions. Empirical data from multiple studies underscore the unique epidemiological and clinical patterns of Mpox in women. In the United States, a small percentage of Mpox cases were reported among cisgender women, with a notable portion involving non-Hispanic Black or African American, non-Hispanic White, and Hispanic or Latino ethnicities. The primary transmission route was identified as sexual or close intimate contact, with the virus predominantly manifesting on the legs, arms, and genital areas. Further, a study in Spain highlighted significant disparities in diagnosis delays, transmission modes, and clinical manifestations between genders, indicating a different risk profile and disease progression in women. Additionally, a case from Vietnam, linked to a new Mpox sub-lineage in women, emphasized the role of women in the transmission dynamics and the importance of genomic monitoring. This review emphasizes the necessity for inclusive surveillance and research to fully understand Mpox dynamics across diverse population groups, including women. Highlighting gender and sexual orientation in public health responses is crucial for an effective approach to managing the spread and impact of this disease. The findings advocate for a gender-diverse assessment in health services and further research to explore the nuances of Mpox transmission, behavior, and progression among different groups, thereby enhancing the global response to Mpox and similar public health challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. ID2 Promotes Lineage Transition of Prostate Cancer through FGFR and JAK-STAT Signaling.
- Author
-
Zhang, Jinxiong, Chen, Zhihao, Mao, Yongxin, He, Yijun, Wu, Xin, Wu, Jianhong, and Sheng, Lu
- Subjects
CELL differentiation ,FIBROBLAST growth factors ,IN vitro studies ,IN vivo studies ,CELL receptors ,CELLULAR signal transduction ,JANUS kinases ,DNA-binding proteins ,RESEARCH funding ,ANDROGEN receptors ,PROSTATE tumors ,DRUG resistance in cancer cells ,PHENOTYPES - Abstract
Simple Summary: Androgen receptor-negative prostate cancer is one of the important mechanisms of castration resistant prostate cancer. The application of next generation androgen receptor signaling pathway inhibitors (ARPIs) has led to a gradual increase of AR-negative prostate cancer in the clinic. In this paper, we demonstrated the potential promotional role of ID2 in androgen receptor-negative prostate cancer through extensive bioinformatics analysis and experimental studies. Through transcriptome sequencing and downstream functional enrichment analysis, we found that ID2 can activate neuroendocrine or stemness-related pathways and inhibit androgen receptor signaling pathways. ID2 can activate JAK/STAT signaling pathway as well as FGFR signaling pathway to promote the acquisition of prostate cancer lineage plasticity, which in turn leads to androgen receptor-negative prostate cancer. Through cell function experiments and mouse experiments, we reveal that ID2 can promote prostate cancer evolution. Using transcriptome sequencing and publicly available clinical data, we generated ID2-related gene signatures to help determine clinical prognosis. The use of androgen receptor pathway inhibitors (ARPIs) has led to an increase in the proportion of AR-null prostate cancer, including neuroendocrine prostate cancer (NEPC) and double-negative prostate cancer (DNPC), but the mechanism underlying this lineage transition has not been elucidated. We found that ID2 expression was increased in AR-null prostate cancer. In vitro and in vivo studies confirmed that ID2 promotes PCa malignancy and can confer resistance to enzalutamide in PCa cells. We generated an ID2 UP50 signature, which is capable of determining resistance to enzalutamide and is valuable for predicting patient prognosis. Functional experiments showed that ID2 could activate stemness-associated JAK/STAT and FGFR signaling while inhibiting the AR signaling pathway. Our study indicates a potentially strong association between ID2 and the acquisition of a stem-like phenotype in adenocarcinoma cells, leading to resistance to androgen deprivation therapy (ADT) and next-generation ARPIs in prostate cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Influential Factors Affecting Recycling Behavior toward Cardboard Boxes in the Logistics Sector: An Empirical Analysis from China.
- Author
-
Li, Pengfei, Ru, Yutao, and Wu, Jianhong
- Abstract
With the escalating issues of resource waste and environmental pollution, the effective recycling of cardboard boxes within the logistics sector has emerged as a crucial factor in advancing sustainable development. This study employs the extended theory of planned behavior (ETPB) to devise a questionnaire and gather data from 700 respondents in China, aiming to analyze the influential factors that impact consumers' engagement in recycling mechanisms provided by express delivery companies. Utilizing a principal component analysis, five co-factors that influence consumers' willingness to recycle are identified. The findings of a multinomial logistic regression reveal a positive correlation between these five co-factors and recycling behavior, with attitude exhibiting the greatest significant influence (5.076 times in model 1 and 2.375 times in model 2) on recycling behavior. These results will serve as a scientific foundation for express delivery companies and governmental entities to adapt and optimize existing environmental protection policies, thus fostering sustainable development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. A Nanoenzyme Constructed from Manganese and Strandberg-Type Phosphomolybdate with Versatility in Antioxidant and Modulating Conformation of A β Protein Misfolding Aggregates In Vitro.
- Author
-
Hua, Jiai, Wang, Feng, Wei, Xueman, Qin, Yuxin, Lian, Jiameng, Wu, Jianhong, Ma, Pengtao, and Ma, Xiang
- Subjects
REACTIVE oxygen species ,SINGLE crystals ,ALZHEIMER'S disease ,FREE radicals ,ETHYLENEDIAMINE - Abstract
Amyloid β-peptide (Aβ) misfolding aggregates with β-sheet structures and surplus reactive oxygen species (ROS) are both considered to be the culprit of neuronal toxicity in Alzheimer's disease (AD). Therefore, modulating the misfolding mode of Aβ and inhibiting ROS simultaneous has become an important method for anti-AD. Herein, a nanoscale manganese-substituted polyphosphomolybdate (H
2 en)3 [Mn(H2 O)4 ][Mn(H2 O)3 ]2 [P2 Mo5 O23 ]2 ·14.5H2 O (abbreviated as MnPM) (en = ethanediamine) was designed and synthesized by single crystal to single crystal transformation method. MnPM can modulate the β-sheet rich conformation of Aβ aggregates, and thus reduce the formation of toxic species. Moreover, MnPM also possesses the ability to eliminate the free radicals produced by Cu2+ -Aβ aggregates. It can inhibit the cytotoxicity of β-sheet-rich species and protect synapses of PC12 cells. MnPM combines the conformation modulating ability of Aβ and anti-oxidation ability, which makes a promising multi-funcational molecular with a composite mechanism for the new conceptual designing in treatment of such protein-misfolding diseases. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Forecasting the Effect of Pre-Exposure Prophylaxis (PrEP) on HIV Propagation with a System of Differential–Difference Equations with Delay.
- Author
-
Adimy, Mostafa, Molina, Julien, Pujo-Menjouet, Laurent, Ranson, Grégoire, and Wu, Jianhong
- Subjects
DIFFERENTIAL-difference equations ,HIV ,PRE-exposure prophylaxis ,HIV infections - Abstract
The HIV/AIDS epidemic is still active worldwide with no existing definitive cure. Based on the WHO recommendations stated in 2014, a treatment, called Pre-Exposure Prophylaxis (PrEP), has been used in the world, and more particularly in France since 2016, to prevent HIV infections. In this paper, we propose a new compartmental epidemiological model with a limited protection time offered by this new treatment. We describe the PrEP compartment with an age-structure hyperbolic equation and introduce a differential equation on the parameter that governs the PrEP starting process. This leads us to a nonlinear differential–difference system with discrete delay. After a local stability analysis, we prove the global behavior of the system. Finally, we illustrate the solutions with numerical simulations based on the data of the French Men who have Sex with Men (MSM) population. We show that the choice of a logistic time dynamics combined with our Hill-function-like model leads to a perfect data fit. These results enable us to forecast the evolution of the HIV epidemics in France if the populations keep using PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Solid Fe Resources Separated from Rolling Oil Sludge for CO Oxidation.
- Author
-
Gao, Wei, Tang, Sai, Wu, Ting, Wu, Jianhong, Cheng, Kai, and Xia, Minggui
- Subjects
FERRIC nitrate ,SURFACES (Technology) ,SOLIDS ,OXIDATION ,RAW materials ,SURFACE area ,CATALYTIC hydrogenation - Abstract
The efficient recycling of valuable resources from rolling oil sludge (ROS) to gain new uses remains a formidable challenge. In this study, we reported the recycling of solid Fe resources from ROS by a catalytic hydrogenation technique and its catalytic performance for CO oxidation. The solid Fe resources, after calcination in air (Fe
2 O3 -H), exhibited comparable activity to those prepared by the calcinations of ferric nitrate (Fe2 O3 -C), suggesting that the solid resources have excellent recycling value when used as raw materials for CO oxidation catalyst preparation. Further studies to improve the catalytic performance by supporting the materials on high surface area 13X zeolite and by pretreating the materials with CO atmosphere, showed that the CO pretreatment greatly improved the CO oxidation activity and the best activity was achieved on the 20 wt.%Fe2 O3 -H/13X sample with complete CO conversion at 250 °C. CO pretreatment could produce more oxygen vacancies, facilitating O2 activation, and thus accelerate the CO oxidation reaction rate. The excellent reducibility and sufficient O2 adsorption amount were also favorable for its performance. The recycling of solid Fe resources from ROS is quite promising for CO oxidation applications. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
8. Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic
- Author
-
Mahroum, Naim, Watad, Abdulla, Bridgewood, Charlie, Mansour, Muhammad, Nasr, Ahmad, Hussein, Amr, Khamisy-Farah, Rola, Farah, Raymond, Gendelman, Omer, Lidar, Merav, Shoenfeld, Yehuda, Amital, Howard, Kong, Jude Dzevela, Wu, Jianhong, Bragazzi, Nicola Luigi, and McGonagle, Dennis
- Subjects
COVID-19 ,Tocilizumab ,Systematic Review and Meta-Analysis - Abstract
Background. Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid therapy and safety were unproven despite widespread use in numerous studies, mostly open label at the start of the pandemic. Methods: We performed a systematic review and meta-analysis of case-control studies utilising tocilizumab in COVID-19 on different databases (PubMed/MEDLINE/Scopus) and preprint servers (medRxiv and SSRN) from inception until 20 July 2020 (PROSPERO CRD42020195690). Subgroup analyses and meta-regressions were performed. The impact of tocilizumab and concomitant corticosteroid therapy or tocilizumab alone versus standard of care (SOC) on the death rate, need for mechanical ventilation, ICU admission and bacterial infections were assessed. Results. Thirty-nine studies with 15,531 patients (3657 cases versus 11,874 controls) were identified. Unadjusted estimates (n = 28) failed to demonstrate a protective effect of tocilizumab on survival (OR 0.74 ([95%CI 0.55-1.01], p = 0.057), mechanical ventilation prevention (OR 2.21 [95%CI 0.53-9.23], p = 0.277) or prevention of ICU admission (OR 3.79 [95%CI 0.38-37.34], p = 0.254). Considering studies with adjusted, estimated, tocilizumab use was associated with mortality rate reduction (HR 0.50 ([95%CI 0.38-0.64], p < 0.001) and prevention of ICU admission (OR 0.16 ([95%CI 0.06-0.43], p < 0.001). Tocilizumab with concomitant steroid use versus SOC was protective with an OR of 0.49 ([95%CI 0.36-0.65], p < 0.05) as was tocilizumab alone versus SOC with an OR of 0.59 ([95%CI 0.34-1.00], p < 0.001). Risk of infection increased (2.36 [95%CI 1.001-5.54], p = 0.050; based on unadjusted estimates). Conclusion: Despite the heterogeneity of included studies and large number of preprint articles, our findings from the first eight of the pandemic in over 15,000 COVID-19 cases suggested an incremental efficacy of tocilizumab in severe COVID-19 that were confirmed by subsequent meta-analyses of large randomized trials of tocilizumab. This suggests that analysis of case-control studies and pre-print server data in the early stages of a pandemic appeared robust for supporting incremental benefits and lack of major therapeutic toxicity of tocilizumab for severe COVID-19. Canadian Institutes of Health Research (CIHR)
- Published
- 2021
9. Modeling COVID-19 Outbreaks in Long-Term Care Facilities Using an Agent-Based Modeling and Simulation Approach.
- Author
-
Asgary, Ali, Blue, Hudson, Solis, Adriano O., McCarthy, Zachary, Najafabadi, Mahdi, Tofighi, Mohammad Ali, and Wu, Jianhong
- Published
- 2022
- Full Text
- View/download PDF
10. Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa.
- Author
-
Mellado, Bruce, Wu, Jianhong, Kong, Jude Dzevela, Bragazzi, Nicola Luigi, Asgary, Ali, Kawonga, Mary, Choma, Nalamotse, Hayasi, Kentaro, Lieberman, Benjamin, Mathaha, Thuso, Mbada, Mduduzi, Ruan, Xifeng, Stevenson, Finn, and Orbinski, James
- Published
- 2021
- Full Text
- View/download PDF
11. Development of an Early Alert System for an Additional Wave of COVID-19 Cases Using a Recurrent Neural Network with Long Short-Term Memory.
- Author
-
Stevenson, Finn, Hayasi, Kentaro, Bragazzi, Nicola Luigi, Kong, Jude Dzevela, Asgary, Ali, Lieberman, Benjamin, Ruan, Xifeng, Mathaha, Thuso, Dahbi, Salah-Eddine, Choma, Joshua, Kawonga, Mary, Mbada, Mduduzi, Tripathi, Nidhi, Orbinski, James, Mellado, Bruce, and Wu, Jianhong
- Published
- 2021
- Full Text
- View/download PDF
12. Managing SARS-CoV-2 Testing in Schools with an Artificial Intelligence Model and Application Developed by Simulation Data.
- Author
-
Valtchev, Svetozar Zarko, Asgary, Ali, Chen, Michael, Cronemberger, Felippe A., Najafabadi, Mahdi M., Cojocaru, Monica Gabriela, and Wu, Jianhong
- Subjects
SARS-CoV-2 ,ARTIFICIAL intelligence ,SOCIAL impact ,MACHINE learning ,SCHOOL rules & regulations - Abstract
Research on SARS-CoV-2 and its social implications have become a major focus to interdisciplinary teams worldwide. As interest in more direct solutions, such as mass testing and vaccination grows, several studies appear to be dedicated to the operationalization of those solutions, leveraging both traditional and new methodologies, and, increasingly, the combination of both. This research examines the challenges anticipated for preventative testing of SARS-CoV-2 in schools and proposes an artificial intelligence (AI)-powered agent-based model crafted specifically for school scenarios. This research shows that in the absence of real data, simulation-based data can be used to develop an artificial intelligence model for the application of rapid assessment of school testing policies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Illicit Drug Use in Canada and Implications for Suicidal Behaviors, and Household Food Insecurity: Findings from a Large, Nationally Representative Survey.
- Author
-
Bragazzi, Nicola Luigi, Beamish, Dan, Kong, Jude Dzevela, and Wu, Jianhong
- Published
- 2021
- Full Text
- View/download PDF
14. Gynecology Meets Big Data in the Disruptive Innovation Medical Era: State-of-Art and Future Prospects.
- Author
-
Khamisy-Farah, Rola, Furstenau, Leonardo B., Kong, Jude Dzevela, Wu, Jianhong, Bragazzi, Nicola Luigi, Tchounwou, Paul B., and Paoletti, Anna Maria
- Published
- 2021
- Full Text
- View/download PDF
15. Artificial Intelligence Model of Drive-Through Vaccination Simulation.
- Author
-
Asgary, Ali, Valtchev, Svetozar Zarko, Chen, Michael, Najafabadi, Mahdi M., and Wu, Jianhong
- Published
- 2021
- Full Text
- View/download PDF
16. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic.
- Author
-
Asgary, Ali, Najafabadi, Mahdi M., Karsseboom, Richard, and Wu, Jianhong
- Subjects
PANDEMICS ,COVID-19 pandemic ,VACCINATION ,COVID-19 vaccines ,COVID-19 ,DISCRETE event simulation - Abstract
Several research and development teams around the world are working towards COVID-19 vaccines. As vaccines are expected to be developed and produced, preparedness and planning for mass vaccination and immunization will become an important aspect of the pandemic management. Mass vaccination has been used by public health agencies in the past and is being proposed as a viable option for COVID-19 immunization. To be able to rapidly and safely immunize a large number of people against SARS-CoV-2, different mass vaccination options are available. Drive-through facilities have been successfully used in the past for immunization against other diseases and for testing during COVID-19. In this paper we introduce a drive-through vaccination simulation tool that can be used to enhance the planning, design, operation, and feasibility and effectiveness assessment of such facilities. The simulation tool is a hybrid model that integrates discrete event and agent-based modeling techniques. The simulation outputs visually and numerically show the average processing and waiting times and the number of cars and people that can be served (throughput values) under different numbers of staff, service lanes, screening, registration, immunization, and recovery times. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic.
- Author
-
Bragazzi, Nicola Luigi, Dai, Haijiang, Damiani, Giovanni, Behzadifar, Masoud, Martini, Mariano, and Wu, Jianhong
- Published
- 2020
- Full Text
- View/download PDF
18. De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study.
- Author
-
Tang, Biao, Scarabel, Francesca, Bragazzi, Nicola Luigi, McCarthy, Zachary, Glazer, Michael, Xiao, Yanyu, Heffernan, Jane M., Asgary, Ali, Ogden, Nicholas Hume, and Wu, Jianhong
- Subjects
SOCIAL distancing ,COVID-19 ,CONTACT tracing ,COVID-19 pandemic ,QUARANTINE ,PREVENTIVE medicine - Abstract
Since the beginning of the COVID-19 pandemic, most Canadian provinces have gone through four distinct phases of social distancing and enhanced testing. A transmission dynamics model fitted to the cumulative case time series data permits us to estimate the effectiveness of interventions implemented in terms of the contact rate, probability of transmission per contact, proportion of isolated contacts, and detection rate. This allows us to calculate the control reproduction number during different phases (which gradually decreased to less than one). From this, we derive the necessary conditions in terms of enhanced social distancing, personal protection, contact tracing, quarantine/isolation strength at each escalation phase for the disease control to avoid a rebound. From this, we quantify the conditions needed to prevent epidemic rebound during de-escalation by simply reversing the escalation process. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data.
- Author
-
Riccò, Matteo, Ferraro, Pietro, Gualerzi, Giovanni, Ranzieri, Silvia, Henry, Brandon Michael, Said, Younes Ben, Pyatigorskaya, Natalia Valeryevna, Nevolina, Elena, Wu, Jianhong, Bragazzi, Nicola Luigi, and Signorelli, Carlo
- Subjects
SARS-CoV-2 ,COVID-19 pandemic ,DIAGNOSIS methods ,HEALTH facilities ,POINT-of-care testing - Abstract
SARS-CoV-2 is responsible for a highly contagious infection, known as COVID-19. SARS-CoV-2 was discovered in late December 2019 and, since then, has become a global pandemic. Timely and accurate COVID-19 laboratory testing is an essential step in the management of the COVID-19 outbreak. To date, assays based on the reverse-transcription polymerase chain reaction (RT-PCR) in respiratory samples are the gold standard for COVID-19 diagnosis. Unfortunately, RT-PCR has several practical limitations. Consequently, alternative diagnostic methods are urgently required, both for alleviating the pressure on laboratories and healthcare facilities and for expanding testing capacity to enable large-scale screening and ensure a timely therapeutic intervention. To date, few studies have been conducted concerning the potential utilization of rapid testing for COVID-19, with some conflicting results. Therefore, the present systematic review and meta-analysis was undertaken to explore the feasibility of rapid diagnostic tests in the management of the COVID-19 outbreak. Based on ten studies, we computed a pooled sensitivity of 64.8% (95%CI 54.5–74.0), and specificity of 98.0% (95%CI 95.8–99.0), with high heterogeneity and risk of reporting bias. We can conclude that: (1) rapid diagnostic tests for COVID-19 are necessary, but should be adequately sensitive and specific; (2) few studies have been carried out to date; (3) the studies included are characterized by low numbers and low sample power, and (4) in light of these results, the use of available tests is currently questionable for clinical purposes and cannot substitute other more reliable molecular tests, such as assays based on RT-PCR. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions.
- Author
-
Tang, Biao, Wang, Xia, Li, Qian, Bragazzi, Nicola Luigi, Tang, Sanyi, Xiao, Yanni, and Wu, Jianhong
- Subjects
COVID-19 ,BASIC reproduction number ,TRAVEL restrictions ,PUBLIC health ,INFECTION prevention - Abstract
Since the emergence of the first cases in Wuhan, China, the novel coronavirus (2019-nCoV) infection has been quickly spreading out to other provinces and neighboring countries. Estimation of the basic reproduction number by means of mathematical modeling can be helpful for determining the potential and severity of an outbreak and providing critical information for identifying the type of disease interventions and intensity. A deterministic compartmental model was devised based on the clinical progression of the disease, epidemiological status of the individuals, and intervention measures. The estimations based on likelihood and model analysis show that the control reproduction number may be as high as 6.47 (95% CI 5.71–7.23). Sensitivity analyses show that interventions, such as intensive contact tracing followed by quarantine and isolation, can effectively reduce the control reproduction number and transmission risk, with the effect of travel restriction adopted by Wuhan on 2019-nCoV infection in Beijing being almost equivalent to increasing quarantine by a 100 thousand baseline value. It is essential to assess how the expensive, resource-intensive measures implemented by the Chinese authorities can contribute to the prevention and control of the 2019-nCoV infection, and how long they should be maintained. Under the most restrictive measures, the outbreak is expected to peak within two weeks (since 23 January 2020) with a significant low peak value. With travel restriction (no imported exposed individuals to Beijing), the number of infected individuals in seven days will decrease by 91.14% in Beijing, compared with the scenario of no travel restriction. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. The Impact of the Freight Transport Modal Shift Policy on China's Carbon Emissions Reduction.
- Author
-
Chen, Shuling, Wu, Jianhong, and Zong, Yueqi
- Abstract
How to reduce the negative transport externalities, especially its carbon emissions, without having significant negative influence on economic and social development is the key for sustainable development in China. This paper explores the impacts of China's recent modal shift policy on carbon emissions, summaries experience from China, and points out future development directions. The paper first compares the different energy consumption and carbon emissions between the road freight transport and the railways in China, and then has a scenarios analysis on China's energy consumption and carbon emissions of the transport sector in 2025. The latest progress and major problems of modal shift policy in China are presented, and a methodology to address this problem is also proposed. Based on the methodology, we compare the benefits and costs brought by modal shift policy in the case of Ordos, Inner Mongolia. Based on the results, principles and suggestions on how to design and implement more efficient modal shift policy are proposed. We find that road transport is the most polluting mode among various modes of transport, and the railway transport has the least carbon emissions. Furthermore, the modal shift policy plays a positive role in carbon emissions, but the costs caused by the policy are higher than the benefits at some circumstances. Moreover, to achieve the sustainable modal shift policy by relying on the feasible market mechanism, together with scientific and effective regulation, instead of "one size for all" administrative policy, are likely the way forward. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic.
- Author
-
Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, Khamisy-Farah R, Farah R, Gendelman O, Lidar M, Shoenfeld Y, Amital H, Kong JD, Wu J, Bragazzi NL, and McGonagle D
- Subjects
- Antibodies, Monoclonal, Humanized, Humans, SARS-CoV-2, Standard of Care, Treatment Outcome, Pandemics, COVID-19 Drug Treatment
- Abstract
Background: Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid therapy and safety were unproven despite widespread use in numerous studies, mostly open label at the start of the pandemic., Methods: We performed a systematic review and meta-analysis of case-control studies utilising tocilizumab in COVID-19 on different databases (PubMed/MEDLINE/Scopus) and preprint servers (medRxiv and SSRN) from inception until 20 July 2020 (PROSPERO CRD42020195690). Subgroup analyses and meta-regressions were performed. The impact of tocilizumab and concomitant corticosteroid therapy or tocilizumab alone versus standard of care (SOC) on the death rate, need for mechanical ventilation, ICU admission and bacterial infections were assessed., Results: Thirty-nine studies with 15,531 patients (3657 cases versus 11,874 controls) were identified. Unadjusted estimates ( n = 28) failed to demonstrate a protective effect of tocilizumab on survival (OR 0.74 ([95%CI 0.55-1.01], p = 0.057), mechanical ventilation prevention (OR 2.21 [95%CI 0.53-9.23], p = 0.277) or prevention of ICU admission (OR 3.79 [95%CI 0.38-37.34], p = 0.254). Considering studies with adjusted, estimated, tocilizumab use was associated with mortality rate reduction (HR 0.50 ([95%CI 0.38-0.64], p < 0.001) and prevention of ICU admission (OR 0.16 ([95%CI 0.06-0.43], p < 0.001). Tocilizumab with concomitant steroid use versus SOC was protective with an OR of 0.49 ([95%CI 0.36-0.65], p < 0.05) as was tocilizumab alone versus SOC with an OR of 0.59 ([95%CI 0.34-1.00], p < 0.001). Risk of infection increased (2.36 [95%CI 1.001-5.54], p = 0.050; based on unadjusted estimates)., Conclusion: Despite the heterogeneity of included studies and large number of preprint articles, our findings from the first eight of the pandemic in over 15,000 COVID-19 cases suggested an incremental efficacy of tocilizumab in severe COVID-19 that were confirmed by subsequent meta-analyses of large randomized trials of tocilizumab. This suggests that analysis of case-control studies and pre-print server data in the early stages of a pandemic appeared robust for supporting incremental benefits and lack of major therapeutic toxicity of tocilizumab for severe COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
23. Artificial Intelligence Model of Drive-Through Vaccination Simulation.
- Author
-
Asgary A, Valtchev SZ, Chen M, Najafabadi MM, and Wu J
- Subjects
- COVID-19 prevention & control, COVID-19 Vaccines administration & dosage, Humans, Pandemics, Artificial Intelligence, Mass Vaccination organization & administration
- Abstract
Planning for mass vaccination against SARS-Cov-2 is ongoing in many countries considering that vaccine will be available for the general public in the near future. Rapid mass vaccination while a pandemic is ongoing requires the use of traditional and new temporary vaccination clinics. Use of drive-through has been suggested as one of the possible effective temporary mass vaccinations among other methods. In this study, we present a machine learning model that has been developed based on a big dataset derived from 125K runs of a drive-through mass vaccination simulation tool. The results show that the model is able to reasonably well predict the key outputs of the simulation tool. Therefore, the model has been turned to an online application that can help mass vaccination planners to assess the outcomes of different types of drive-through mass vaccination facilities much faster.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.